Aurinia Pharmaceuticals I... (AUPH)
Aurinia Pharmaceuticals Max Pain By Strike
AUPH trades at $12.21, 52.6% above the near-term max pain of $8 expiring Sep 19, 2025 (31 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($7-$13), signaling increased put positioning or downside protection. High dispersion in max pain levels suggests competing forces and potential volatility.
Aurinia Pharmaceuticals Max Pain By Expiry
Max pain for AUPH shows a downward trend from 13 to 7, indicating bearish sentiment or hedging activity. The 64% spread signals divergent expectations across timeframes. Most levels below 12.21 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 8 | -4.21 (-34.51%) |
| Oct 17, 2025 | 9 | -3.21 (-26.32%) |
| Jan 16, 2026 | 7 | -5.21 (-42.69%) |
| Apr 17, 2026 | 13 | 0.79 (6.43%) |
| Jan 15, 2027 | 10 | -2.21 (-18.13%) |